Oral gene therapy for hypoparathyroidism: A rat model

Fong Fu Chou, Shun Chen Huang, Shwu Fen Chang, Jiahorng Liaw, Pei Hua Hung

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA in vivo was investigated. Parathyroid hormone (PTH)(1?34) gene (179 bp) was inserted into a human cytomegalovirus promoter (PCMV) and E. coli competent cells were used to amplify the cDNA. Polymeric micelle formations (100 νl) formed from PCMV-PTH(1-34) cDNA (7.2 μg/μl) and 6% (w=v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48 hr and then at 8-hr intervals for 24 hr weekly for 3 weeks. Parathyroidectomized rats receiving 150 μl of EDTA (10mM) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10mM), PCMV-PTH(1?34) cDNA and PCMV-PTH(1?34) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1?34) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1?34), reverse transcriptase polymerase chain reaction for PTH(1?34) mRNA and the relative density of PTH(1?34) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1?34) were higher in the study than in the control groups. In the study group, positive stain of PTH(1?34) and PTH(1?34) mRNA could be found in those organs. Relative densities of PTH(1?34) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1?34) levels in parathyroidectomized rats.

Original languageEnglish
Pages (from-to)1344-1350
Number of pages7
JournalHuman Gene Therapy
Volume20
Issue number11
DOIs
Publication statusPublished - Nov 1 2009

Fingerprint

Hypoparathyroidism
Parathyroid Hormone
Genetic Therapy
Complementary DNA
Edetic Acid
Messenger RNA
Specific Gravity
Micelles
Calcium
Drinking Water
Control Groups
Coloring Agents
Parathyroidectomy
Polypropylenes
Reverse Transcriptase Polymerase Chain Reaction
Serum
Cytomegalovirus
Oxides

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Medicine(all)

Cite this

Oral gene therapy for hypoparathyroidism : A rat model. / Chou, Fong Fu; Huang, Shun Chen; Chang, Shwu Fen; Liaw, Jiahorng; Hung, Pei Hua.

In: Human Gene Therapy, Vol. 20, No. 11, 01.11.2009, p. 1344-1350.

Research output: Contribution to journalArticle

Chou, Fong Fu ; Huang, Shun Chen ; Chang, Shwu Fen ; Liaw, Jiahorng ; Hung, Pei Hua. / Oral gene therapy for hypoparathyroidism : A rat model. In: Human Gene Therapy. 2009 ; Vol. 20, No. 11. pp. 1344-1350.
@article{5c1c9ece02dc4d60a7c3051cdff6f2fb,
title = "Oral gene therapy for hypoparathyroidism: A rat model",
abstract = "The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA in vivo was investigated. Parathyroid hormone (PTH)(1?34) gene (179 bp) was inserted into a human cytomegalovirus promoter (PCMV) and E. coli competent cells were used to amplify the cDNA. Polymeric micelle formations (100 νl) formed from PCMV-PTH(1-34) cDNA (7.2 μg/μl) and 6{\%} (w=v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48 hr and then at 8-hr intervals for 24 hr weekly for 3 weeks. Parathyroidectomized rats receiving 150 μl of EDTA (10mM) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10mM), PCMV-PTH(1?34) cDNA and PCMV-PTH(1?34) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1?34) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1?34), reverse transcriptase polymerase chain reaction for PTH(1?34) mRNA and the relative density of PTH(1?34) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1?34) were higher in the study than in the control groups. In the study group, positive stain of PTH(1?34) and PTH(1?34) mRNA could be found in those organs. Relative densities of PTH(1?34) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1?34) levels in parathyroidectomized rats.",
author = "Chou, {Fong Fu} and Huang, {Shun Chen} and Chang, {Shwu Fen} and Jiahorng Liaw and Hung, {Pei Hua}",
year = "2009",
month = "11",
day = "1",
doi = "10.1089/hum.2009.015",
language = "English",
volume = "20",
pages = "1344--1350",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Oral gene therapy for hypoparathyroidism

T2 - A rat model

AU - Chou, Fong Fu

AU - Huang, Shun Chen

AU - Chang, Shwu Fen

AU - Liaw, Jiahorng

AU - Hung, Pei Hua

PY - 2009/11/1

Y1 - 2009/11/1

N2 - The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA in vivo was investigated. Parathyroid hormone (PTH)(1?34) gene (179 bp) was inserted into a human cytomegalovirus promoter (PCMV) and E. coli competent cells were used to amplify the cDNA. Polymeric micelle formations (100 νl) formed from PCMV-PTH(1-34) cDNA (7.2 μg/μl) and 6% (w=v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48 hr and then at 8-hr intervals for 24 hr weekly for 3 weeks. Parathyroidectomized rats receiving 150 μl of EDTA (10mM) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10mM), PCMV-PTH(1?34) cDNA and PCMV-PTH(1?34) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1?34) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1?34), reverse transcriptase polymerase chain reaction for PTH(1?34) mRNA and the relative density of PTH(1?34) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1?34) were higher in the study than in the control groups. In the study group, positive stain of PTH(1?34) and PTH(1?34) mRNA could be found in those organs. Relative densities of PTH(1?34) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1?34) levels in parathyroidectomized rats.

AB - The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA in vivo was investigated. Parathyroid hormone (PTH)(1?34) gene (179 bp) was inserted into a human cytomegalovirus promoter (PCMV) and E. coli competent cells were used to amplify the cDNA. Polymeric micelle formations (100 νl) formed from PCMV-PTH(1-34) cDNA (7.2 μg/μl) and 6% (w=v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48 hr and then at 8-hr intervals for 24 hr weekly for 3 weeks. Parathyroidectomized rats receiving 150 μl of EDTA (10mM) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10mM), PCMV-PTH(1?34) cDNA and PCMV-PTH(1?34) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1?34) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1?34), reverse transcriptase polymerase chain reaction for PTH(1?34) mRNA and the relative density of PTH(1?34) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1?34) were higher in the study than in the control groups. In the study group, positive stain of PTH(1?34) and PTH(1?34) mRNA could be found in those organs. Relative densities of PTH(1?34) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1?34) levels in parathyroidectomized rats.

UR - http://www.scopus.com/inward/record.url?scp=70449105221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449105221&partnerID=8YFLogxK

U2 - 10.1089/hum.2009.015

DO - 10.1089/hum.2009.015

M3 - Article

C2 - 19619000

AN - SCOPUS:70449105221

VL - 20

SP - 1344

EP - 1350

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 11

ER -